81
SOUTH SAN FRANCISCO, Calif. — August 29, 2025 — Leads & Copy — Alumis Inc. (Nasdaq: ALMS) will participate in several investor conferences in September, the biopharma company announced today. The conferences include:
- Cantor Global Healthcare Conference 2025 in New York, NY on September 3 at 9:45 am ET (fireside chat);
- Wells Fargo 2025 Healthcare Conference in Boston, MA on September 5 at 9:30 am ET (fireside chat);
- Morgan Stanley 23rd Annual Global Healthcare Conference in New York, NY on September 8 at 4:50 pm ET (fireside chat);
- H.C. Wainwright 27th Annual Global Investment Conference in New York, NY on September 9 at 10:30 am ET (presentation);
- Baird 2025 Global Healthcare Conference in New York, NY on September 10 at 2:35 pm ET (presentation); and
- Stifel 2025 Virtual Immunology & Inflammation Forum on September 16 at 12:30 pm ET (virtual presentation)
Live webcasts can be accessed on the “Events” page of the “Investors” section of the Alumis website. Webcast replays will be archived on the company’s website for 90 days.
Alumis is a late-stage biopharma company developing next-generation targeted therapies for immune-mediated diseases.
Contact: Teri Dahlman, Red House Communications, teri@redhousecomms.com
Source: Alumis
